A Study of IMP4297 as Maintenance Treatment Following First-line Chemotherapy in Patients With Advanced Ovarian Cancer
Clinical trial NCT04169997 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04169997
- Sponsor
- Impact Therapeutics, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-12-24
- Primary completion
- 2023-03-16
- Enrollment
- 404
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.